INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: INT230-6|OTHER: Saline injection
Sponsor: Ottawa Hospital Research Institute
Collaborators: Intensity Therapeutics, Inc.|Ontario Institute for Cancer Research